Inventor
MIER WALTER
DE22 patents
⚠️ This page may combine multiple inventors who share the name “MIER WALTER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DEUTSCHES KREBSFORSCH
8 patentsUS11045564B2Jun 29, 2021
Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancer
DEUTSCHES KREBSFORSCH10 citations93
US10398791B2Sep 3, 2019
Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
DEUTSCHES KREBSFORSCH22 citations93
US10471160B2Nov 12, 2019
Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
DEUTSCHES KREBSFORSCH16 citations91
US6369109B1Apr 9, 2002
Betulinic acid and derivatives thereof useful for the treatment of neuroectodermal tumor
DEUTSCHES KREBSFORSCH33 citations86
US6417339B1Jul 9, 2002
Dendrimers based on saccharides
DEUTSCHES KREBSFORSCH19 citations85
US11951190B2Apr 9, 2024
Use of labeled inhibitors of prostate specific membrane antigen (PSMA), as agents for the treatment of prostate cancer
DEUTSCHES KREBSFORSCH4 citations84
US11931430B2Mar 19, 2024
Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancer
DEUTSCHES KREBSFORSCH5 citations84
US6891033B2May 10, 2005
Labelling compounds for the simple synthesis of 3'-[18F]fluoro-3'-deoxythymidine and a method for the production thereof
DEUTSCHES KREBSFORSCH5 citations55
MIER WALTER
4 patentsUS9562076B2Feb 7, 2017
Hydrophobic modified pres-derived peptides of hepatitis B virus (HBV) and their use as HBV and HDV entry inhibitors
MIER WALTER8 citations81
US9868768B2Jan 16, 2018
Hydrophobic modified pres-derived peptides of hepatitis B virus (HBV) and their use as vehicles for the specific delivery of compounds to the liver
MIER WALTER1 citations49
US10513539B2Dec 24, 2019
Hydrophobic modified peptides and their use for liver specific targeting
MIER WALTER0 citations45
US10363323B2Jul 30, 2019
Hydrophobic modified peptides for liver specific diagnosis
MIER WALTER0 citations33
MERCK PATENT GMBH
3 patentsUS10065993B2Sep 4, 2018
Peptides and peptide/active compound conjugates for renal targeting
MERCK PATENT GMBH7 citations82
US10413614B2Sep 17, 2019
Conjugates for protection from nephrotoxic active substances
MERCK PATENT GMBH0 citations50
US9808535B2Nov 7, 2017
Conjugates for protection from nephrotoxic active substances
MERCK PATENT GMBH1 citations50
UNIV HEIDELBERG RUPRECHT KARLS
3 patentsUS10253099B2Apr 9, 2019
Conjugates of proteins and multivalent cell-penetrating peptides and their uses
UNIV HEIDELBERG RUPRECHT KARLS3 citations70
US11401304B2Aug 2, 2022
Cyclic NTCP-targeting peptides and their uses as entry inhibitors
UNIV HEIDELBERG RUPRECHT KARLS1 citations61
US11202833B2Dec 21, 2021
Methylglyoxal-scavenging cyclic peptides and their use for the prevention and treatment of diseases associated with elevated methylglyoxal levels
UNIV HEIDELBERG RUPRECHT KARLS0 citations49